关于FT3/FT4对糖尿病病的预测效应:一项对中国T2DM患者住院的甲状腺关节患者的探索性研究
Xin Zhao1, Jianbin Sun1, Sixu Xin1
1Department of Endocrinology, Peking University International Hospital, Beijing 102206, China.
Biomedicines
|August 26, 2023
概括
较低的自由三甲状腺素 (FT3) 与自由甲状腺素 (FT4) 的比率 (FT3/FT4) 与2型糖尿病 (T2DM) 患者糖尿病病 (DKD) 的风险更高有关. 这一发现强调了FT3/FT4比率作为DKD的潜在预测指标.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 糖尿病病 (DKD) 是2型糖尿病 (T2DM) 的一个主要并发症.
- 甲状腺激素水平,特别是自由三甲状腺素 (FT3) 与自由甲状腺素 (FT4) (FT3/FT4) 的比例,可能在代谢调节和疾病进展中发挥作用.
研究的目的:
- 研究FT3/FT4比率与T2DM患者的DKD患病率之间的关联.
- 确定FT3/FT4比率作为该人群中DKD的潜在独立预测因子.
主要方法:
- 对1729名T2DM患者的回顾性分析.
- 根据FT3/FT4比率,患者被分为三组.
- 统计分析包括后勤回归来确定风险因素.
主要成果:
- 在FT3/FT4比率组之间,糖化血红蛋白 (HbA1c),禁食血糖 (FBG) 和食后血糖 (PBG) 的显著差异.
- 最低的FT3/FT4比率组表现出DKD的最高流行率.
- 低FT3/FT4比率被确定为DKD的一个独立风险因素 (OR = 2.36,p = 0.01).
结论:
- 降低FT3/FT4比率是T2DM患者DKD发生的独立预测因素.
- 在T2DM中,FT3/FT4比率可以作为评估DKD风险的有价值生物标志物.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
01:25Chronic Kidney Disease I: Introduction
35
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
35
01:11Renal Failure: Dose Adjustments
121
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
121
01:24Chronic Kidney Disease II: Clinical Manifestations
29
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
29
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34